Terns Pharmaceuticals, Inc. Share Price
TERNTerns Pharmaceuticals, Inc. Stock Performance
Open $20.70 | Prev. Close $20.14 | Circuit Range N/A |
Day Range $19.93 - $21.09 | Year Range $1.86 - $21.09 | Volume 75,171 |
Average Traded $20.41 |
Terns Pharmaceuticals, Inc. Share Price Chart
About Terns Pharmaceuticals, Inc.
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
Terns Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $20.70 | $20.12 | +0.00% |
12-Nov-25 | $20.70 | $20.12 | -2.24% |
11-Nov-25 | $19.20 | $20.58 | +7.58% |
10-Nov-25 | $18.95 | $19.13 | +3.55% |
07-Nov-25 | $17.95 | $18.48 | +1.34% |
06-Nov-25 | $17.91 | $18.23 | +0.30% |
05-Nov-25 | $17.20 | $18.18 | +4.42% |
FAQs on Terns Pharmaceuticals, Inc. Share Price
Can I buy Terns Pharmaceuticals, Inc. shares in India?
What is the share price of Terns Pharmaceuticals, Inc.?
What is the 5 year returns of Terns Pharmaceuticals, Inc.?
What are the high & low stock price of Terns Pharmaceuticals, Inc. today?
What is the 52-week high and low of Terns Pharmaceuticals, Inc. stock?